• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 4. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyloxycarbonyls

Recent Advances in the Application of Benzyl 2,3-Dihydropyrrole-1-carboxylate (CAS: 68471-57-8) in Chemical Biology and Pharmaceutical Research

Benzyl 2,3-dihydropyrrole-1-carboxylate (CAS: 68471-57-8) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This compound, characterized by its pyrrolidine core and benzyl ester functionality, serves as a key building block for the synthesis of various bioactive molecules. Recent studies have explored its utility in the development of novel therapeutic agents, particularly in the areas of anti-inflammatory, anticancer, and antimicrobial drug design.

A 2023 study published in the *Journal of Medicinal Chemistry* demonstrated the efficacy of benzyl 2,3-dihydropyrrole-1-carboxylate derivatives as potent inhibitors of cyclooxygenase-2 (COX-2), an enzyme implicated in inflammatory diseases. The researchers utilized a structure-activity relationship (SAR) approach to optimize the compound's scaffold, resulting in derivatives with improved selectivity and reduced gastrointestinal toxicity compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs). These findings highlight the potential of this compound as a starting point for developing safer anti-inflammatory therapies.

In the field of oncology, benzyl 2,3-dihydropyrrole-1-carboxylate has been investigated as a precursor for the synthesis of small-molecule kinase inhibitors. A recent *Bioorganic & Medicinal Chemistry Letters* publication (2024) reported the design and evaluation of novel pyrrolidine-based compounds targeting the epidermal growth factor receptor (EGFR), a well-validated target in cancer treatment. The study revealed that modifications to the benzyl ester group of 68471-57-8 significantly influenced the compounds' binding affinity and cellular permeability, leading to improved antitumor activity in vitro and in vivo.

The compound's utility extends to antimicrobial drug development as well. Researchers have incorporated the benzyl 2,3-dihydropyrrole-1-carboxylate scaffold into novel quorum-sensing inhibitors, which disrupt bacterial communication and virulence without exerting selective pressure for resistance development. A 2024 *European Journal of Medicinal Chemistry* paper detailed the synthesis of such analogs and their efficacy against multidrug-resistant *Pseudomonas aeruginosa* strains, showcasing the compound's potential in addressing the global antimicrobial resistance crisis.

From a synthetic chemistry perspective, recent advancements have focused on developing more efficient and sustainable routes to produce benzyl 2,3-dihydropyrrole-1-carboxylate. A 2023 *Green Chemistry* article described a biocatalytic approach using engineered enzymes to achieve the asymmetric synthesis of this compound with high enantioselectivity, addressing previous challenges in obtaining optically pure derivatives. This methodological innovation opens new possibilities for the production of chiral drug candidates based on this scaffold.

In conclusion, benzyl 2,3-dihydropyrrole-1-carboxylate (CAS: 68471-57-8) continues to emerge as a valuable chemical entity in pharmaceutical research. Its structural versatility enables diverse medicinal chemistry applications, from anti-inflammatory and anticancer agents to novel antimicrobials. The recent studies highlighted in this briefing demonstrate the compound's growing importance in drug discovery and underscore the need for further investigation into its therapeutic potential. As synthetic methodologies advance and biological understanding deepens, this scaffold is poised to contribute significantly to the development of next-generation therapeutics.

• 1155-64-2(H-Lys(Z)-OH)
• 2899-07-2(Cbz-N-methyl-L-phenylalanine)
• 3589-42-2((S)-Benzyl (1-cyano-3-methylbutyl)carbamate)
• 6216-63-3(Z-Pro-OL)
• 6372-14-1(N-Benzyloxycarbonyl-L-phenylalaninol)
• 1138-80-3(Z-Glycine)
• 1148-11-4(Carbobenzoxyproline)
• 2304-94-1(Z-β-Ala-OH)
• 6404-31-5((2R)-1-benzyloxycarbonylpyrrolidine-2-carboxylic acid)
• 3304-51-6((2S)-2-amino-5-(benzyloxycarbonylamino)pentanoic acid)